Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Fighting Blindness Retinal Degeneration Fund Foundation currently holds 3,236,171 shares of Opus Genetics, Inc. (IRD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Fighting Blindness Retinal Degeneration Fund Foundation has been a net seller of IRD stock. They have purchased $0 and sold $18.8M worth of shares.
Fighting Blindness Retinal Degeneration Fund Foundation's most recent insider trade was on Sep 30, 2026, when they sold 556,000 shares at $4.96 per share.
Fighting Blindness Retinal Degeneration Fund Foundation serves as Executive at Opus Genetics, Inc. (IRD). They have executed 3 insider transactions totaling $18.8M over their tenure at the company.
Fighting Blindness Retinal Degeneration Fund Foundation holds the position of Executive at Opus Genetics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Fighting Blindness Retinal Degeneration Fund Foundation has shown a selling trading pattern, with $0 in total purchases and $18.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Fighting Blindness Retinal Degeneration Fund Foundation was on Dec 9, 2025, when they sold $8.6M worth of IRD shares. This transaction involved 4,000,000 shares at $2.15 per share.
Fighting Blindness Retinal Degeneration Fund Foundation currently owns 3,236,171 shares of Opus Genetics, Inc. (IRD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Fighting Blindness Retinal Degeneration Fund Foundation's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Fighting Blindness Retinal Degeneration Fund Foundation has 3 Form 4 filings on record as an insider at Opus Genetics, Inc..
Set alerts for Fighting Blindness Retinal Degeneration Fund Foundation and 40,000+ other insiders.